1-hydroxy-2(1h)-pyridinone has been researched along with plutonium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abergel, RJ; An, DD; Bjornstad, KA; Choi, TA; Gauny, SS; Morales-Rivera, JA; Rosen, CJ; Sturzbecher-Hoehne, M; Villalobos, JA | 1 |
| Angulo, JF; Bohand, S; Griffiths, NM; Van der Meeren, A | 1 |
2 other study(ies) available for 1-hydroxy-2(1h)-pyridinone and plutonium
| Article | Year |
|---|---|
(238)Pu elimination profiles after delayed treatment with 3,4,3LI(1,2HOPO) in female and male Swiss-Webster mice.
Topics: Animals; Body Burden; Chelating Agents; Chelation Therapy; Dose-Response Relationship, Drug; Female; Heterocyclic Compounds, 1-Ring; Kidney; Liver; Male; Mice; Plutonium; Pyridones; Sex Factors; Time Factors | 2014 |
A quick and simple in vitro assay to predict bioavailability of actinides following accidental exposure.
Topics: Americium; Biological Assay; Biological Availability; Body Fluids; Bone and Bones; Chelating Agents; Citrates; Colloids; Lung; Nitrates; Pentetic Acid; Plutonium; Pyridones; Radiation Exposure; Radioactive Hazard Release; Transferrin; Uranium | 2019 |